PERICARDIUM DISEASES
https://doi.org/10.15829/1560-4071-2016-1-90-98
Abstract
The lecture summarizes published and our own data on etiology, diagnostics, management, prevention and prediction of pericarditis (PC), that is currently the most common type of pericardium diseases (PD) and quite common cause of chest pain. Causes of PD differ and usually are related to infections (viral and bacterial), neoplasms (primary and secondary), autoimmune disorders (connective tissue diseases and vasculitides), drugs and the syndrome of pericardial damage. Idiopathic/viral PC is the most common type of PD and shows recurrence in one third of patients. the diagnosis is based upon clinical and instrumental criteria (ECG, EchoCG, cardiac MR I, pericardium biopsy). In acute PC the most common treatments are NSAIDs, antiviral drugs and, additionally, colchicine (first line treatment). New treatment for recurrent PC is intravenous immunoglobulins or anakinra (second line treatment). In our own last series of patients the evolution of PD causes has been marked: tendency to increase of specific types of PC (tuberculosis, autoimmune) and appearance of novel iatrogenic types after cardiovascular interventions. Therapy with non-steroidal antinflammatory drugs and colchicine do decrease the rate of recurrents.
About the Authors
A. A. Dyomin
Novosibirsk State Medical University, Novosibirsk, Russia
Russian Federation
Russian Federation
V. P. Drobysheva
Novosibirsk State Medical University, Novosibirsk, Russia
Russian Federation
Russian Federation
References
1. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. Eur. Heart J. 2015. http://dx.doi.org/eart10.1093/eurheartj/ehv318.
2. Demin AA. Perikardit. Kardiologija. M.: Medicina, 2006, p. 728-57. Russian (Демин А. А. Перикардит. Кардиология (рук-во для врачей). М.: Медицина, 2006, с. 728-57).
3. Demin AA, Drobysheva VP. Pericarditis in internal medicine. Cardiovascular Therapy and Prevention 2005; 4(4): 134. Suppl. 1. Rusian (Демин А. А., Дробышева В. П . Перикардит в клинике внутренних болезней. Кардиоваскулярная терапия и профилактика, 2005; 4(4):134, приложение).
4. Gouriet F, Levy PY, Casalta JP, et al. Etiology of pericarditis in a prospective cohort of 1162 cases. Am J Med- 2015; 128: 784 — e.1-8.
5. Imazio M, Gaita F. Diagnosis and treatment of pericarditis. Heart 2015; 101: 1159-68.
6. Imazio M, Belli R, Brucato A, et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebocontrolled, randomised trial. Lancet 2014; 383: 2232-37.
7. Imazio M, Cecchi E, Demichelis B, et al. Indicators of poor prognosis of acute pericarditis. Circulation 2007; 115: 2739-44.
8. Imazio M, Lazaros G, Brucato A, et al. Intravenous human immunoglobulin for refractory recurrent pericarditis. A systematic review of all published cases. J Cardiovasc Med 2015; Jun 18 [Epub ahead of print].
9. Kataoka G, Nakano K, Asano R, et al. Purulent pericardial effusion and mycotic pseudoaneurysm following insertion of a bare metal stent. J Card Surg 2015; 30 (5):433-5.
10. Lazaros G, Imazio M, Brucato A, et al. Anakinra: an emerging option for refractory idiopathic recurrent pericarditis. A systematic review of published evidence. J Cardiovasc Med (Hagerstown) 2015; Jun 18 [Epub ahead of print].
11. Morel N, Bonjour M, Le Guern C, et al. Colchicine: a simple and effective treatment for pericarditis in systemic lupus erythematosus? A report of 10 cases. Lupus 2015; July 10. 24(14). DOI: 10.1177/0961203315593169.
12. Rakhshan E, M irabbasi S, Khaligh B, Pericarditis-Induced Hyponatremia after Cardiac Electronic Implantable Device Procedures. Am J Case Rep 2015; 16: 245-9.
13. Reuter H, Burgess L, van Vuuren W, et al. Diagnosing tuberculous pericarditis. QJM 2006; 99(12): 827-39.
Review
For citations:
Dyomin A.A., Drobysheva V.P. PERICARDIUM DISEASES. Russian Journal of Cardiology. 2016;(1):90-98. (In Russ.) https://doi.org/10.15829/1560-4071-2016-1-90-98
Views:
1457
Email this article 